Access to anti-retroviral drugs, female in Lithuania
Lithuania: Access to anti-retroviral drugs, female was 56.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Lithuania, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Lithuania stood at 56.0%. That is the highest value across all 25 years on record.
That represents a change of up 9.8% on the previous year and up 273.3% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Lithuania peaked at 56.0% in 2024 and was at its lowest, 0.0%, in 2000.
Lithuania ranks 110th of 141 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Lithuania, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 1.0% | — |
| 2004 | 2.0% | +100.0% |
| 2005 | 2.0% | +0.0% |
| 2006 | 3.0% | +50.0% |
| 2007 | 4.0% | +33.3% |
| 2008 | 5.0% | +25.0% |
| 2009 | 6.0% | +20.0% |
| 2010 | 7.0% | +16.7% |
| 2011 | 8.0% | +14.3% |
| 2012 | 11.0% | +37.5% |
| 2013 | 20.0% | +81.8% |
| 2014 | 15.0% | -25.0% |
| 2015 | 22.0% | +46.7% |
| 2016 | 25.0% | +13.6% |
| 2017 | 27.0% | +8.0% |
| 2018 | 35.0% | +29.6% |
| 2019 | 37.0% | +5.7% |
| 2020 | 38.0% | +2.7% |
| 2021 | 39.0% | +2.6% |
| 2022 | 45.0% | +15.4% |
| 2023 | 51.0% | +13.3% |
| 2024 | 56.0% | +9.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 2.3% | 0.0% | 6.0% | 10 |
| 2010s | 20.7% | 7.0% | 37.0% | 10 |
| 2020s | 45.8% | 38.0% | 56.0% | 5 |
Countries ranked near Lithuania
More gender data for Lithuania
- Child population (UN estimates and projections) 361.11 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -2.94 % change on previous year (2030)
- Population 2,345 (2030)
- Working-age population (UN estimates and projections) 2,345 (2030)
- Population (UN estimates and projections), annual growth rate -0.4774 % change on previous year (2030)
- Age population, age 00, female, interpolated 10,620 (2025)
- Age population, age 00, male, interpolated 11,194 (2025)
- Age population, age 01, female, interpolated 10,662 (2025)
- Age population, age 01, male, interpolated 11,224 (2025)
- Age population, age 02, female, interpolated 10,961 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Lithuania?
- Access to anti-retroviral drugs, female in Lithuania was 56.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Lithuania?
- The highest recorded value was 56.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Lithuania?
- The lowest recorded value was 0.0% in 2000.
- How does Lithuania rank for access to anti-retroviral drugs, female?
- Lithuania ranks 110th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Lithuania?
- Over the last ten years it is up 273.3%. The long-run trend across the full record is volatile.
- Where does this Lithuania data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.